Dolby Laboratories (NYSE:DLB – Get Free Report) SVP John Couling sold 7,666 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $55.62, for a total transaction of $426,382.92. Following the completion of the sale, the senior vice president owned 118,727 shares of the company’s stock, valued at approximately $6,603,595.74. This trade represents a 6.07% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Dolby Laboratories Stock Performance
Shares of NYSE DLB opened at $54.91 on Thursday. The company has a market cap of $5.19 billion, a PE ratio of 21.70 and a beta of 0.81. The business has a 50-day simple moving average of $59.16 and a two-hundred day simple moving average of $62.78. Dolby Laboratories has a fifty-two week low of $52.45 and a fifty-two week high of $77.00.
Dolby Laboratories (NYSE:DLB – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The business had revenue of $395.63 million during the quarter, compared to the consensus estimate of $385.80 million. During the same quarter last year, the company earned $1.34 earnings per share. The company’s quarterly revenue was up 7.0% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, sell-side analysts predict that Dolby Laboratories will post 3.21 earnings per share for the current fiscal year.
Dolby Laboratories Announces Dividend
Analysts Set New Price Targets
Several research firms have recently commented on DLB. Barrington Research reiterated an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a research note on Monday, April 27th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a report on Friday, March 27th. Finally, Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Dolby Laboratories presently has an average rating of “Moderate Buy” and an average target price of $90.75.
Get Our Latest Stock Report on DLB
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. raised its position in Dolby Laboratories by 2.7% during the third quarter. Vanguard Group Inc. now owns 7,756,924 shares of the electronics maker’s stock valued at $561,369,000 after acquiring an additional 203,411 shares in the last quarter. State Street Corp raised its position in Dolby Laboratories by 8.7% during the second quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock valued at $167,906,000 after acquiring an additional 180,072 shares in the last quarter. First Trust Advisors LP raised its position in Dolby Laboratories by 19.9% during the first quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock valued at $135,431,000 after acquiring an additional 374,405 shares in the last quarter. Geode Capital Management LLC raised its position in Dolby Laboratories by 15.6% during the fourth quarter. Geode Capital Management LLC now owns 1,885,246 shares of the electronics maker’s stock valued at $122,749,000 after acquiring an additional 254,250 shares in the last quarter. Finally, AQR Capital Management LLC raised its position in Dolby Laboratories by 51.8% during the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock valued at $128,935,000 after acquiring an additional 592,282 shares in the last quarter. 58.56% of the stock is currently owned by hedge funds and other institutional investors.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Read More
- Five stocks we like better than Dolby Laboratories
- As AI Data Breaches Become More Common, This Cybersecurity ETF Is SurgingAI
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
